Providers responded to the statement, “I feel comfortable ordering a pharmacogenetic test to predict risk of adverse events or likelihood of response (e.g., CYP2C9/VKORC1 and warfarin therapy)”. Percentages responding ‘agree’ or ‘strongly agree’ were adjusted for respondents' role, age and gender. Error bars represent 95% CIs.
CI: Confidence interval; PGx: Pharmacogenomic.